Nobel Prize winner Jennifer Doudna is the most well-known co-founder of CRISPR start-up Mammoth Biosciences, but Janice Chen, the sister of U.S. figure skating champion Nathan Chen, is also one of its four co-founders and the chief technology officer.
- Mammoth has added $100 million in big pharma contracts and government grants since the pandemic began, quadrupled its employee count and is still hiring, and saw its valuation rise to $1 billion in a venture deal featuring Amazon and Apple’s Tim Cook.
- Chen has her sights set on reaching a $100 billion valuation as an independent company.
- See CNBC article on CRISPR startup by
Rebecca Fannin
